Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Proof of Principle Program - Phase I

University of Toronto

$160,000.00

Development of the Mammalian Membrane Two-Hybrid (MaMTH) technology, a novel protein interaction and drug discovery tool

EF 2012-13

Résumé
Every cell in the human body contains proteins. They are major part of the skin, muscles, organs, glands and also body fluids. While carrying out the essential functions of our body, proteins don't work in isolation, they form living machines, complexes of dozens of proteins that fit together like a jigsaw puzzle. To see the whole picture and to understand how biochemical process work in our cells, scientists need to identify which pieces, or proteins, fit next to or interact directly with each other. Among all proteins in human cells, a special role can be assigned to those associated with cellular membranes (so called membrane proteins) because their malfunctioning contributes to many human diseases including cancer, cardiovascular, neurodegenerative diseases and developmental disorders. However, due to their complex chemical features the study of membrane proteins has historically been extremely problematic making the study of their interacting proteins even more challenging. The purpose of this proposal is to develop and implement a novel assay that can detect and monitor protein-protein interactions in human cells for this most difficult class of proteins. Such a method may have great applications for the field of molecular medicine since it may be used to identify novel proteins as components of many essential cellular processes. Furthermore, this assay will be of importance for the field of drug discovery since it may be used to identify drugs that disrupt a defined set of membrane protein interactions that occur only in a certain human disease.
Programme
Proof of Principle Program - Phase I
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
268522
Name
Stagljar Igor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Proof of Principle
Projecttitle
Development of the Mammalian Membrane Two-Hybrid (MaMTH) technology, a novel protein interaction and drug discovery tool
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$160,000
Cihrequipment2
$0
Programname2
Proof of Principle Program - Phase I
Keyworddelim
Cancer Research; Drug Assay Platform; High-Throughput Protein Interaction Assay; Mammalian Membrane Two Hybrid; Protein Protein Interaction; Signalling Pathways
Abstract
Every cell in the human body contains proteins. They are major part of the skin, muscles, organs, glands and also body fluids. While carrying out the essential functions of our body, proteins don't work in isolation, they form living machines, complexes of dozens of proteins that fit together like a jigsaw puzzle. To see the whole picture and to understand how biochemical process work in our cells, scientists need to identify which pieces, or proteins, fit next to or interact directly with each other. Among all proteins in human cells, a special role can be assigned to those associated with cellular membranes (so called membrane proteins) because their malfunctioning contributes to many human diseases including cancer, cardiovascular, neurodegenerative diseases and developmental disorders. However, due to their complex chemical features the study of membrane proteins has historically been extremely problematic making the study of their interacting proteins even more challenging. The purpose of this proposal is to develop and implement a novel assay that can detect and monitor protein-protein interactions in human cells for this most difficult class of proteins. Such a method may have great applications for the field of molecular medicine since it may be used to identify novel proteins as components of many essential cellular processes. Furthermore, this assay will be of importance for the field of drug discovery since it may be used to identify drugs that disrupt a defined set of membrane protein interactions that occur only in a certain human disease.
Competitiondate
201209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Stagljar, Igor
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $160,000~ $0~